Why do you suppose it has been so difficult for Recursion to keep a CSO (been without since 8/2021) and a CMO (been without since 6/2022)? How do you feel like the lack of such experienced leadership has affected your ability rapidly translate your insights into medicines?
Neat_Caterpillar_7592 karma
Why do you suppose it has been so difficult for Recursion to keep a CSO (been without since 8/2021) and a CMO (been without since 6/2022)? How do you feel like the lack of such experienced leadership has affected your ability rapidly translate your insights into medicines?
View HistoryShare Link